Skip to Main Content

Paper Details

A Phase 2 Randomized Pilot Study Comparing High-Dose-Rate Brachytherapy and Low-Dose-Rate Brachytherapy as Monotherapy in Localized Prostate Cancer.
Adv Radiat Oncol
21
2019
HDRB, IPSS, Iodine, Iridium-192, LDRB, Localized Prostate Cancer, Men, Prostate Cancer, Prostate Symptom, localized prostate cancer, patients, prostate cancer, urinary incontinence
Author NameAffiliation
Yaqun WangSchool of Public Health, Rutgers Cancer Institute of New Jersey, Rutgers University
Eric VigneaultDepartment of Radiation Oncology and Research Centre CHU de Quebec-Universite Laval
  • 1 - 2

Datasets

Release 1.2